Molecular dynamics, MM/PBSA and in vitro validation of a novel quinazoline-based EGFR tyrosine kinase inhibitor identified using structure-based in silico screening
Narittira Ornnork, Duangnapa Kiriwan, Kriengsak Lirdprapamongkol, Kiattawee Choowongkomon, Jisnuson Svasti, Chatchakorn Eurtivong
Topics & Concepts
Virtual screeningQuinazolineLapatinibChemistryEGFR inhibitorsDocking (animal)AfatinibSmall moleculeMoleculeIn silicoMolecular dynamicsEpidermal growth factor receptorStereochemistryBiochemistryPharmacophoreBiologyGefitinibComputational chemistryReceptorCancerMedicineGeneticsGeneOrganic chemistryBreast cancerTrastuzumabNursingCancer therapeutics and mechanismsQuinazolinone synthesis and applicationsLung Cancer Treatments and Mutations